In addition to the immunosuppressive functions, FOXP3+ Tregs have been demonstrated as a major source of RANKL [71], the critical cytokine required for osteoclasts differentiation as well as cancer cell mobility and bone metastasis [72], suggesting RANKL+ Tregs may promote DTC recruitment to the bone. The gene discussed is TNFSF11; the disease is cancer.